Table 3.
Follow-up data in patients with ST-segment elevation in lead aVR based on lead aVR ST-segment elevation <1.5mm and ≥1.5mm.
| ST-Segment Changes in Lead aVR <1.5mm (n=37) | ST-Segment Changes in Lead aVR ≥1.5mm (n=39) | p-value | |
|---|---|---|---|
| In-hospital clinical pathway, n (%) | |||
| - Pharmacotherapy | 7 (18.9) | 5 (12.8) | 0.466 |
| - PCI | 16 (43.2) | 14 (35.9) | 0.513 |
| - CABG | 6 (16.2) | 8 (20.5) | 0.629 |
| - Patient-Requested Discharge | 8 (21.6) | 12 (30.8) | 0.365 |
| - In-hospital mortality | 2 (5.4) | 5 (12.8) | 0.432f |
| 6-month Follow-up , n (%) | |||
| - Rehospitalization Events | 9 (24.3) | 15 (41.7) | 0.278f |
| - Accompanying Procedures (angiography and CABG) | 7 (20.6) | 15 (44.1) | 0.092f |
| - Mortality , n (%) | 4 (11.8) | 3 (8.8) | 1.000 |
Abbreviations: PCI: percutaneous coronary intervention; CABG: coronary artery bypass grafting.
f: p-values are resulted from fisher’s exact test.